Morgan Stanley Biovie Inc. Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Biovie Inc. stock. As of the latest transaction made, Morgan Stanley holds 24,601 shares of BIVI stock, worth $11,070. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,601
Previous 83,025
70.37%
Holding current value
$11,070
Previous $104,000
87.5%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding BIVI
# of Institutions
57Shares Held
7MCall Options Held
51.7KPut Options Held
353K-
Altium Capital Management LP New York, NY3.01MShares$1.36 Million0.9% of portfolio
-
Sabby Management, LLC Upper Saddle River, NJ689KShares$310,11012.47% of portfolio
-
Vanguard Group Inc Valley Forge, PA645KShares$290,0580.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE600KShares$269,9532.37% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny347KShares$156,3300.0% of portfolio
About BIOVIE INC.
- Ticker BIVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,165,300
- Market Cap $13.6M
- Description
- BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...